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Abstract
Bone Morphogenetic Protein 15 (BMP15) is a TGFβ-like oocyte-derived growth factor involved in ovarian
folliculogenesis as a critical regulator of many granulosa cell processes. Alterations of the BMP15 gene have been
found associated with different ovarian phenotypic effects depending on the species, from sterility to increased
prolificacy in sheep, slight subfertility in mouse or associated with primary ovarian insufficiency (POI) in women. To
investigate the evolving role of BMP15, a phylogenetic analysis of this particular TGFβ family member was
performed. A maximum likelihood phylogenetic tree of several TGFβ/BMP family members expressed by the ovary
showed that BMP15 has a very strong divergence and a rapid evolution compared to others. Moreover, among 24
mammalian species, we detected signals of positive selection in the hominidae clade corresponding to F146, L189
and Y235 residues in human BMP15. The biological importance of these residues was tested functionally after site
directed-mutagenesis in a COV434 cells luciferase assay. By replacing the positively selected amino acid either by
alanine or the most represented residue in other studied species, only L189A, Y235A and Y235C mutants showed a
significant increase of BMP15 signaling when compared to wild type. Additionally, the Y235C mutant was more
potent than wild type in inhibiting progesterone secretion of ovine granulosa cells in primary culture. Interestingly, the
Y235C mutation was previously identified in association with POI in women. In conclusion, this study evidences that
the BMP15 gene has evolved faster than other members of the TGFß family and was submitted to a positive
selection pressure in the hominidae clade. Some residues under positive selection are of great importance for the
normal function of the protein and thus for female fertility. Y235 represents a critical residue in the determination of
BMP15 biological activity, thus indirectly confirming its role in the onset of POI in women.
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Introduction
BMP15 is an oocyte-derived growth factor belonging to the
transforming growth factor-beta (TGFβ) superfamily, which is
involved in ovarian follicular development as a critical regulator
of many granulosa cell (GC) processes such as proliferation
and steroidogenesis [1-4]. Similarly to other TGFβ/BMP factors,
BMP15 is first synthesized as a pro-form processed by
cleavage to liberate a mature form with biological activity and a
large pro-domain [5,6]. After the removal of the signal peptide,
the pro-protein dimerizes first and then undergoes proteolytic
cleavage at a conserved RXXR cleavage site [2,3,7,8]. The
pro-region is known to have an important role in the processing
of the pro-protein by driving the dimerization and the
subsequent secretion of the active mature dimers. BMP15
action in the ovary was first discovered in sheep with the
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evidence of six different natural “loss-of-function” mutations,
two in the pro-region and four in the mature domain [4].
Heterozygous carrier ewes have increased ovulation rate, but
homozygous carrier ewes show a blockade at the primary
stage of folliculogenesis leading to sterility [9-12]. Unlike
mutated BMP15 homozygous ewes, bmp15 null female mice
are fertile but exhibit a slight decrease in ovulation rate with
minimal ovarian histopathological defects [13]. Interestingly
heterozygous bmp15 invalidated mice never exhibit increased
ovulation rate as observed in sheep. Thus, the role of BMP15
appears to differ between species. This protein, associated
with increased ovulation rate when altered in mono-ovulating
sheep, seems to be dispensable in mouse, a poly-ovulating
species. Recent findings are in agreement with this concept.
Firstly, mouse seems to lack a biologically active Bmp15
molecule [14] and secondly, over-expression of a biologically
active BMP15 in mice leads to accelerate folliculogenesis and
causes an early decline in the ovarian reserve. Therefore, the
lack of biologically active BMP15 during folliculogenesis in the
wild type mice may be relevant to their polyovulatory nature
[15]. Then, the BMP15 gene has become a strong candidate
gene for genetic alterations associated with human ovarian
pathologies. In women, mutations in BMP15 have been found
associated with both primary and secondary amenorrhea in
several primary ovarian insufficiency (POI) cohorts with
prevalence between 1.5% and 15% [16]. POI, a more
appropriate definition of premature ovarian failure, is a disorder
associated with female infertility affecting 1 to 2% of women
under 40 years old, thus representing one major cause of
female infertility [17]. Up to now, more than a dozen of
mutations in BMP15 have been described associated with POI
[16]. Most of the POI-associated BMP15 mutations are
missense mutations found at the heterozygous state and
located in the pro-region part of the protein. When tested
functionally, these mutations hampered the protein processing
and the biological activity, consistent with a mechanism of
haploinsufficiency [18].
Regarding all the above data, the BMP15 gene is the target
of numerous mutations associated with altered ovarian function
in different species, which highlights its crucial role in female
fertility but with species-specific differences. To our knowledge,
experimental and functional results of positive selection of gene
involved in vertebrate reproductive functions are missing. The
central hypothesis being examined in this paper is to determine
if BMP15 has evolved under positive selection, and if this
evolution had consequences on the control of ovarian function
in mammals.
Results and Discussion
BMP15 evolution among TGFß family members
We performed a phylogenetic analysis of sereval TGFβ/BMP
family members expressed within the ovary throughout
selected species: human, mouse and rat (Figure 1 and Table
S1). The maximum likelihood (ML) tree we obtained is
consistent with previous TGFß phylogenies made with the
entire pre-pro-proteins sequences [19,20]. BMP15, as well as
GDF9, INHA and AMH (all marker genes of the ovarian
function), evolve more rapidly and are more divergent between
species than the other members of the TGFβ superfamily as
indicated by their high length branches. Specifically, BMP15
evidenced a very strong divergence and a rapid evolution
compared to other BMP genes expressed in the ovary like
other genes encoding proteins involved in reproductive
functions as previously shown [21,22].
BMP15 positive selection events
Given that positive selection is often associated with branch
length and fast gene evolution [23], and that genes involved in
reproduction evolve faster and often evidenced positive
selection [24-26], we carried out positive selection analyses on
BMP15. We used the BMP15 sequences from 24 mammals
(Figure 2 and Table S2) analyzed by branch-site models from
PAML packages [27] within the PhyleasProg web server [28],
in order to determine whether the different species of the
phylogenetic tree underwent selective pressures and to detect
signals of local episodic positive selection. Those analyses
were applied to the full sequence, the pro-region and the
mature form of BMP15. Results for the mature form did not
show any sites under positive selection; this result is not
surprising since this domain is highly conserved among
species. We tested all branches of the phylogenetic tree of
BMP15 pro-region and three branches appeared to be
significant: opossum, orangutan and hominidae (Figure 2 and
Table S3). We identified five positively selected sites for
opossum (W55, S73, D89, G165 and P187); two of these five
amino acids (S73 and P187) were also identified by the
calculation of positive selection using the full sequence of
BMP15. We identified three positively selected sites for the
orangutan (I25, R146 and R215) and three for the hominidae
clade, corresponding in human sequence to F146, L189 and
Y235 (Figure 3A). It has been reported that GC biased gene
conversion (gBGC) [29] could increase the dN/dS ratio,
especially in primates and cause false positive detection of
amino acid in branch-site positive selection study [30,31]. We
know that in hominidae the BMP15 third-codon position GC
rate (53%) is high compared to the gene average in this clade
(46%) [32]. However, a recent study by Gharid and Robinson-
Rechavi [33] shows that the GC content of a sequence did not
significantly affect the branch site model.
Biological activity of the BMP15 positively selected
sites
In order to check the functional role of these three amino
acids in the human BMP15 protein, we performed a luciferase
reporter assay in the granulosa-derived COV434 cell line, as
previously described [18]. We analyzed biological activities of
the human wild type BMP15 compared to those of mutant
variants that have been obtained by site-directed mutagenesis
for the three positions under positive selection. One set of
mutants was obtained by the systematic substitution of the
human wild type amino acid under positive selection by an
Alanine (F146A, L189A and Y235A). The second set of
mutants was obtained by replacing the human wild type amino
acid by the one that is the most represented at the same
position in the other species within the BMP15 multiple
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alignment used for phylogenetic analysis (F146S, L189H and
Y235C, Figure S1). As positive controls, COV434 cells
expressing the luciferase reporter gene showed an activation of
the BMP signaling pathway when stimulated with 100 ng of the
exogenous recombinant human BMP15, or when transiently
transfected with the wild type human BMP15 expressing
construct (Figure 3B). Among our positively selected variants,
BMP15 activity was not affected by the F146 residue
mutations. In contrast, the transfection of Y235A and Y235C
mutants showed a significant enhancement of the BMP
signaling pathway of 24 to 42% compared to the wild type.
Moreover, L189A also increased the BMP15 activity by 34%
(Figure 3B). Accordingly, the human BMP15 secondary
structure prediction by PsiPred [34] revealed that the F146 site
is situated in a coil region, while L189 and Y235 are situated in
the fourth alpha helix and in the eighth beta sheet, respectively
(Figure 3A). This was confirmed by the crystallographic
structure of TGFß1[35] and, thus these positions are suspected
to affect the three-dimensional structure of BMP15.
Additionally, purified recombinant human BMP15 proteins were
assayed on their ability to modulate the progesterone synthesis
by granulosa cells. When compared to wild type, recombinant
human BMP15Y235C was dose-dependently more potent in
inhibiting progesterone secretion by ovine granulosa cells in
primary culture (Figure 4). Indeed, the significant biological
action of BMP15Y235C started at 10ng/ml compared to 50ng/ml
for the wild type protein. Moreover, at 200ng/ml the inhibiting
action of BMP15Y235C was significantly higher than wild type.
These results were in agreement with the increased signaling
activity of the BMP15Y235C mutant in the COV434 cell assay.
Overall, these findings are consistent with the idea that some
residues under positive selection are of key importance in the
function of the protein. Particularly, Y235 represents a critical
residue in the determination of BMP15 biological activity and
BMP15Y235C was the first mutation found associated with POI in
human [36]. Interestingly, the present functional analysis of this
position indicates that its alteration enhanced the BMP15-
dependent transcriptional activity associated with enhanced
action on granulosa cell steroidogenesis. In contrast,
BMP15Y235C was unable to increase granulosa cells proliferation
as previously shown [36]. This could indicate a discriminant
action of this mutation on BMP15-dependent signaling on
Figure 1.  BMP15 evolution among TGFß/BMP family members.  Phylogenetic tree of thirteen members of the TGFβ/BMP
superfamily expressed by the mammalian ovary reconstructed using maximum likelihood. Bootstrap values are given when nodes
are strongly supported (>80%). The scale represents the substitution rate.
doi: 10.1371/journal.pone.0078199.g001
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proliferative vs. differentiative function of granulosa cells. The
Y235 residue is situated in the pro-region of BMP15, and it is
known that the pro-region is able to modulate the expression
and activity of the mature protein involving posttranslational
modifications. Chimeric constructs with human BMP15 pro-
region and mouse mature region are able to produce mouse
BMP15 protein in a better way compared to the native mouse
BMP15 pre-protein [14]. Moreover, the substitution of specific
residues in the pro-domain of murine and ovine BMP15 protein
lead to a decrease of the expression and activity of the
chimeric protein compared to the wild type form, when tested
on COV 434 cells [37]. Based on these observations, the
Y235C mutation is probably affecting BMP15 activity through
the posttranslational processing modification of the protein
previously shown [36].
When tested functionally, most of the other BMP15
mutations associated with primary or secondary amenorrhea in
POI women (Figure 3) hampered the protein processing and
the biological activity through the same COV434 luciferase test
[18]. This indicates that the mechanism behind these POI
cases is associated with a loss of BMP15 function.
Nevertheless, the present results may support an inverse
hypothesis i.e. an enhanced BMP15 activity could also be
related to POI. In most of the cases, ovarian insufficiency
occurs because of an anticipated depletion of the primordial
follicular pool within the ovaries, due to a diminished size of the
pool, an accelerated atresia, or an altered recruitment. This fits
very well with the phenotype observed in mice over expressing
a functional BMP15 [15]. Intriguingly, C235 is the wild type
residue observed in chimpanzee (Pan troglodytes). One could
hypothesize that the Y235 to C235 substitution could be
responsible of the high rate of dizygotic twin observed in this
species. Indeed, the chimpanzee dizygotic twinning rate
(2.46%) is over twice the human average. This amino acid
substitution may be positively selected due to a high selection
pressure caused by the P. troglodytes heteropaternity sexual
behavior [38].
Taken together, our data suggest that BMP15 amino-acids
under positive selection (L189 and Y235) may have a
repressive effect on BMP15 biological activity and then may
contribute to limit the anticipated depletion of primordial
follicular pool observed in POI patients. Usually, biological
activities of positive selective sites are associated with an
increase of biological activity. As example, the deletion of the
positively selected amino acids in the SPRY domain in TRIM5α
that has protective effects against viral infections in primates,
leads to the loss of its antiviral activity against HIV-1 and SIV
viruses [39]. Thus, to our knowledge, our study on BMP15 is
the first example of amino acids under positive selection with a
repressive effect.
In this study, we determined that oocyte-expressed BMP15
gene has evolved faster than other members of the TGFß
family and was submitted to a positive selection pressure in the
hominidae clade. Some residues under this positive selection
Figure 2.  BMP15 positive selection pressure among mammals.  Phylogenetic tree of BMP15 from 24 mammals species
reconstructed using TreeBeST and rooted by minimizing with the number of duplications and losses. Bootstrap values are given
when nodes are strongly supported (>80%). Branches or species that have a significant LRT for positive selection calculation are
indicated in bold (threshold of q= 5% of false positives). The scale represents the substitution rate.
doi: 10.1371/journal.pone.0078199.g002
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Figure 3.  Functional analysis of amino acids under positive selection in human BMP15.  A, Human BMP15 full sequence
showing prodomain, cleavage site (underlined) and mature peptide (framed sequence); known human variants for BMP15 found in
POI patients (framed grey highligthed); and identified amino acids under positive selection (framed colored highlighted): BMP15F146,
BMP15L189, BMP15Y235. B, In vitro reporter luciferase assay from COV434 granulosa cells transiently transfected with empty vector
+/- 100ng recombinant human BMP15 (mock +/- BMP15) or wild type human BMP15 expressing vector (WT) or the different BMP15
variants vectors obtained by directed-mutagenesis of residues under positive selection. Results are expressed as the mean (±SD)
of 4 independent experiments. Differences between means were analyzed by one-way ANOVA by comparing each condition to WT
(*, p<0.05; **, p<0;01; ***, p<0.001).
doi: 10.1371/journal.pone.0078199.g003
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are of great importance for the normal function of the protein
and thus for female fertility. Y235 represents a critical residue
in the determination of BMP15 biological activity, confirming its
role in the genetic determinism of POI in women through a
complex and still undefined derangement of BMP15 paracrine
function.
Materials and Methods
Phylogenetic and evolutionary analyses
Thirty-nine protein sequences belonging to the TGFβ
superfamily were retrieved from Ensembl for human, mouse
and rat (Table S1). Multiple sequence alignments were
performed using the MUSCLE algorithm [40]. Phylogenetic tree
was reconstructed using maximum likelihood (ML) in PhyML
3.0 under the LG model [41]. Bootstrap values [42] were
estimated with 1000 replications. BMP15 coding and protein
sequences were retrieved from Ensembl database Release 70
({http://www.ensembl.org/index.html) from 23 mammal species:
armadillo (Dasypus novemcinctus), chimpanzee (Pan
troglodytes), dog (Canis familiaris), dolphin (Tursiops
truncatus), gorilla (Gorilla gorilla), hedgehog (Erinaceus
europaeus), horse (Equus caballus), human (Homo sapiens),
kangaroo rat (Dipodomys ordii), lesser hedgehog tenrec
(Echinops telfairi), macaque (Macaca mulatta), microbat
(Myotis lucifugus), mouse (Mus musculus), opossum
(Monodelphis domestica), orangutan (Pongo abelii), panda
(Ailuropoda melanoleuca), pig (Sus scrofa), platypus
(Ornithorhynchus anatinus), rabbit (Oryctolagus cuniculus), rat
Figure 4.  Recombinant BMP15 inhibition of progesterone
secretion.  Granulosa cells from small antral (1–3 mm in
diameter) ovine follicles were cultured for 96 h in serum-free
conditions. Cultures were performed in the absence (control) or
in the presence of increasing dose (10, 50, 200ng/ml) of wild
type recombinant human BMP15wt or BMP15Y235C mutant. Each
treatment was tested in triplicate in each of 5 independent
experiments. The results represent the amount of progesterone
secreted by 50 000 cells between 48 h and 96 h of culture
(mean ±SEM). Dose effect was analyzed by one-way ANOVA
by comparing each dose to control (**, p<0.01; ***, p<0.001).
Mutation effect was analyzed by Student t-test within each
dose ($, p<0.05).
doi: 10.1371/journal.pone.0078199.g004
(Rattus norvegicus), sloth (Choloepus hoffmanni), tarsier
(Tarsius syrichta), cow (Bos taurus). An additional sequence
was retrieved from NCBI database (http://
www.ncbi.nlm.nih.gov/) for one mammal: sheep (Ovis aries)
(Table S2). Phylogenetic tree and evolutionary analyses were
computed on BMP15 pro-regions (i.e. from the N-terminus to
the consensus cleavage site -RXXR-), on mature domain (i.e.
from the consensus cleavage site –RXXR- to the C-terminus)
and on full coding sequence. Multiple sequence alignment
(MSA), tree reconstruction as well as positive selection
calculation are then computed using the PhyleasProg web
server v3.0 with the “fine” and “orthologs only” options [28]. The
PhyleasProg web server uses the codeml program from the
PAML package [27] to evaluate the ratio ω (ratio of non-
synonymous/synonymous substitution rates, dN/dS), which is a
measure of selective pressure. Values of ω<1, =1 and >1 are
indicators of purifying selection, neutral evolution and positive
selection, respectively. We used branch-site models [43,44],
which permit different branches (or sets of branches) to evolve
under different selective constraints. All branches of the
phylogenetic tree are tested as foreground branch. Two models
are used, one called “alternative” in which the foreground
branch may have some sites under positive selection, and one
called ‘null’ in which positive selection is not allowed for the
foreground branch. For the “alternative” model, three classes
were defined: ω0: dN/dS<1, ω1: dN/dS=1 and ω2: dN/dS≥1,
while in the “null” model, ω2 was fixed to 1. Calculations are
performed on a 272 codons length in order to keep the most
possible informative sites (Figure S1). Likelihood ratio tests
were used to compare log likelihood values between the two
models. In the context of multiple testing, we calculated q-value
measures as an extension of the false discovery rate, using the
q-value package of R [45]. The q-value attached to each
individual branch described the expected proportion of false
positives among all branches equal to or more extreme than
the observed one. Therefore, the thresholding of the estimated
q-values at alpha level =10% produced a list of significant
branches so that the expected proportion of false positives was
alpha. Bayes Empirical Bayes (BEB) method [44] was used to
estimate posterior probabilities of selection on each codon,
probabilities >0.90 were considered for further study.
Construction of BMP15 expression plasmids
BMP15 gene variants were introduced by site-directed
mutagenesis into the pCSBMP15wt vector, containing a full-
length human BMP15 wild type cDNA [18]. Mutagenesis
reaction for each variant was performed using the
QuickChange Site-Directed Mutagenesis kit (Stratagene) and
specific couples of primers (Table S4). Two series of
mutagenesis were performed, the first one by changing the
amino acid under positive selection by an Alanine (chemically
inert) and the second one by the most frequently observed
amino acid in protein alignment of BMP15 among all studied
species (Figure S1). All mutations were checked by DNA
resequencing.
Positive Selection in BMP15
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Transient transfections and luciferase reporter assay
A COV434 human granulosa cells line [46] stably expressing
the BMP responsive element (BRE) - luciferase reporter was
seeded at a density of 500000 cells/well in 12-well plates in
DMEM supplemented with 10% FCS. When subconfluent, cells
were transfected in triplicate with the wild type or mutant pCS2
expression vector (500 ng/well) by using Fugene HD (Roche
Applied Sciences, Indianapolis, IN) following manufacturer’s
protocol. The pCS2 empty vector was used as negative control.
Approximately 24 hr after transfection, the medium was
replaced with 1% serum medium with 100 ng/ml of rhBMP-15
(R&D Systems, Minneapolis, MN) added only in positive control
wells. After 16 hr of treatment, cells were rinsed with ice-cold
PBS and then lysed with 200 ml of Passive Lysis Buffer 1X
(Promega). Cell lysates from each well were centrifuged at
12,000 rpm for 2 minutes to pellet the cell debris and 20 μl of
the supernatants were then assayed for luciferase activity
using the Dual Luciferase reporter Assay kit (Promega).
Luminescence in relative light units (RLU) was measured for 10
s in a Fluoroskan Ascent instrument (Labsystems, Oy,
Finland). Results and statistical analysis (one-way ANOVA
followed by Dunnett’s post-hoc test, GraphPad Prism v6.0)
were then calculated as the mean (±SD) relative to pCS2-
BMP15 wild type expression vector in triplicate in 4 separate
experiments. Differences with P > 0.05 were considered as not
significant.
Ovine granulosa cells culture and progesterone assay
Five cyclic Romanov ewes were treated with intravaginal
progestagen sponges (fluorogestone acetate, 40 mg, Intervet,
Angers, France) for 13 days in order to synchronize estrus. The
ovaries were recovered at slaughtering in the late follicular
phase, 36 h after sponge removal. This procedure was
approved by the ‘‘Direction Départementale des Services
Vétérinaires d’Indre-et-Loire’’ (approval number C37-175-2) for
the agricultural and scientific research agencies INRA (French
National Institute for Agricultural Research) and CNRS (French
National Center for Scientific Research), and conducted in
accordance with the Guide for the Care and Use of Agricultural
Animals in Research and Teaching. Primary granulosa cells
were recovered from ovarian follicles of 1-3mm in diameter and
seeded at 100 000 viable cells/well in 96-well plates and
cultured for 96 h at 37 °C with 5% CO2 in serum- free McCoy
5a medium (Sigma, L’Isle d’Abeau Chesnes, France) as
previouly described [47]. Cultures were performed with or
without 10, 50 and 200ng/ml of recombinant human BMP15 or
BMP15Y235C prepared previously [36]. Culture media were
partially replaced (180 over 250 μl) at 48 h. Media conditioned
between 48 and 96h of culture were collected at 96h and
stored at -20 °C prior to the progesterone assay. At the end of
the culture period, the number of cells per well was estimated
after trypsinization with a hemacytometer under a phase
contrast microscope. Progesterone amounts in the culture
media from each experiment were measured by
radioimmunoassay in the same assay, as described [48]. The
limit of detection of the assay was 12 pg/tube and the intra-
assay coefficient of variation was 10%. The results are
expressed as the amount of progesterone secreted per 50 000
cells recovered at the end of the culture period. Results were
calculated as the mean (±SEM) of triplicate in 5 separate
cultures. Statistical analysis (GraphPad Prism v6.0) for BMP15
dose-effect was performed by one-way ANOVA. Statistical
significance was given relatively to the control condition after
Dunnett’s multiple comparison tests. Mutation effect was tested
by Student t-test within each BMP15 dose. Differences with P >
0.05 were considered as not significant.
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